ASX - By Stock
|
ADO |
Re:
Ann: AnteoTech Signs SE Asian Distribution Agreement for EuGeni
|
|
SarmisGTS
|
320 |
105K |
0 |
19/07/21 |
19/07/21 |
ASX - By Stock
|
320
|
105K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
SarmisGTS
|
1.0K |
415K |
9 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
1.0K
|
415K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Novartis and Mesoblast Remestemcel-L Collaboration
|
|
SarmisGTS
|
811 |
330K |
14 |
27/11/20 |
27/11/20 |
ASX - By Stock
|
811
|
330K
|
14
|
|
ASX - By Stock
|
ADO |
Re:
Sona Nanotech Covid Test Withdrawal.
|
|
SarmisGTS
|
16 |
4.3K |
6 |
26/11/20 |
26/11/20 |
ASX - By Stock
|
16
|
4.3K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Novartis and Mesoblast Remestemcel-L Collaboration
|
|
SarmisGTS
|
811 |
330K |
33 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
811
|
330K
|
33
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Study Confirms Targeted Sensitivity of COVID-19 Test
|
|
SarmisGTS
|
323 |
82K |
7 |
21/10/20 |
21/10/20 |
ASX - By Stock
|
323
|
82K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast Company Update - Webcast and Forward Thoughts
|
|
SarmisGTS
|
273 |
127K |
3 |
08/10/20 |
08/10/20 |
ASX - By Stock
|
273
|
127K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
SarmisGTS
|
17K |
6.5M |
4 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
17K
|
6.5M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
SarmisGTS
|
17K |
6.5M |
1 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
17K
|
6.5M
|
1
|
|
ASX - By Stock
|
ADO |
Re:
ADO: Covid-19 for USA & EU
|
|
SarmisGTS
|
438 |
134K |
28 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
438
|
134K
|
28
|
|
ASX - By Stock
|
ADO |
Re:
ADO Analysis
|
|
SarmisGTS
|
4.3K |
2.5M |
5 |
03/08/20 |
03/08/20 |
ASX - By Stock
|
4.3K
|
2.5M
|
5
|
|
ASX - By Stock
|
AVE |
Re:
The Countdown ...
|
|
SarmisGTS
|
221 |
49K |
2 |
22/07/20 |
22/07/20 |
ASX - By Stock
|
221
|
49K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Dr. Michael Bowdish - Reflections on MSB's NIH Trial
|
|
SarmisGTS
|
185 |
59K |
19 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
185
|
59K
|
19
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
SarmisGTS
|
23K |
13M |
0 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
23K
|
13M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
SarmisGTS
|
23K |
13M |
5 |
04/07/20 |
04/07/20 |
ASX - By Stock
|
23K
|
13M
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
SarmisGTS
|
23K |
13M |
4 |
25/06/20 |
25/06/20 |
ASX - By Stock
|
23K
|
13M
|
4
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho Investor Update
|
|
SarmisGTS
|
76 |
17K |
0 |
17/06/20 |
17/06/20 |
ASX - By Stock
|
76
|
17K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
DELIVERING MORE FOR OUR INVESTORS
|
|
SarmisGTS
|
12 |
2.7K |
2 |
14/06/20 |
14/06/20 |
ASX - By Stock
|
12
|
2.7K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
SarmisGTS
|
1.0K |
485K |
1 |
12/06/20 |
12/06/20 |
ASX - By Stock
|
1.0K
|
485K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
SarmisGTS
|
23K |
13M |
9 |
12/06/20 |
12/06/20 |
ASX - By Stock
|
23K
|
13M
|
9
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
SarmisGTS
|
23K |
13M |
30 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
23K
|
13M
|
30
|
|
ASX - By Stock
|
ADO |
Re:
Our partners
|
|
SarmisGTS
|
936 |
274K |
3 |
09/06/20 |
09/06/20 |
ASX - By Stock
|
936
|
274K
|
3
|
|
ASX - By Stock
|
ADO |
Re:
Our partners
|
|
SarmisGTS
|
936 |
274K |
0 |
08/06/20 |
08/06/20 |
ASX - By Stock
|
936
|
274K
|
0
|
|
ASX - By Stock
|
ADO |
Re:
Our partners
|
|
SarmisGTS
|
936 |
274K |
2 |
08/06/20 |
08/06/20 |
ASX - By Stock
|
936
|
274K
|
2
|
|
ASX - By Stock
|
ADO |
Re:
Our partners
|
|
SarmisGTS
|
936 |
274K |
14 |
08/06/20 |
08/06/20 |
ASX - By Stock
|
936
|
274K
|
14
|
|
ASX - By Stock
|
ADO |
Re:
Our partners
|
|
SarmisGTS
|
936 |
274K |
14 |
07/06/20 |
07/06/20 |
ASX - By Stock
|
936
|
274K
|
14
|
|
ASX - By Stock
|
ADO |
Re:
Our partners
|
|
SarmisGTS
|
936 |
274K |
12 |
07/06/20 |
07/06/20 |
ASX - By Stock
|
936
|
274K
|
12
|
|
ASX - By Stock
|
AVE |
Re:
What was that all about?
|
|
SarmisGTS
|
60 |
12K |
0 |
07/06/20 |
07/06/20 |
ASX - By Stock
|
60
|
12K
|
0
|
|
ASX - By Stock
|
AVE Biotech |
Re:
AGM : questions needing answers
|
|
SarmisGTS
|
36 |
9.5K |
0 |
05/06/20 |
05/06/20 |
ASX - By Stock
|
36
|
9.5K
|
0
|
|
ASX - By Stock
|
AVE Biotech |
Re:
AGM : questions needing answers
|
|
SarmisGTS
|
36 |
9.5K |
4 |
05/06/20 |
05/06/20 |
ASX - By Stock
|
36
|
9.5K
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
SarmisGTS
|
23K |
13M |
10 |
29/05/20 |
29/05/20 |
ASX - By Stock
|
23K
|
13M
|
10
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
SarmisGTS
|
23K |
13M |
0 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
23K
|
13M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
SarmisGTS
|
23K |
13M |
5 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
23K
|
13M
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
SarmisGTS
|
23K |
13M |
4 |
21/05/20 |
21/05/20 |
ASX - By Stock
|
23K
|
13M
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
SarmisGTS
|
23K |
13M |
25 |
21/05/20 |
21/05/20 |
ASX - By Stock
|
23K
|
13M
|
25
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
SarmisGTS
|
23K |
13M |
5 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
23K
|
13M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Competition? What Competition?
|
|
SarmisGTS
|
73 |
32K |
6 |
17/05/20 |
17/05/20 |
ASX - By Stock
|
73
|
32K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
A Bigger Cash Cow for Revascor?
|
|
SarmisGTS
|
45 |
24K |
19 |
10/05/20 |
10/05/20 |
ASX - By Stock
|
45
|
24K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Googala's 2020 Share Price Competitions
|
|
SarmisGTS
|
303 |
102K |
4 |
07/05/20 |
07/05/20 |
ASX - By Stock
|
303
|
102K
|
4
|
|
Charts
|
MSB |
Re:
MSB 2020 charts
|
|
SarmisGTS
|
143 |
261K |
4 |
24/04/20 |
24/04/20 |
Charts
|
143
|
261K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
SarmisGTS
|
17K |
6.5M |
2 |
03/04/20 |
03/04/20 |
ASX - By Stock
|
17K
|
6.5M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
SarmisGTS
|
23K |
13M |
6 |
06/03/20 |
06/03/20 |
ASX - By Stock
|
23K
|
13M
|
6
|
|
ASX - By Stock
|
ADO |
Re:
Renounceable rights issue
|
|
SarmisGTS
|
270 |
2.3M |
0 |
06/03/20 |
06/03/20 |
ASX - By Stock
|
270
|
2.3M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
SarmisGTS
|
23K |
13M |
11 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
23K
|
13M
|
11
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
SarmisGTS
|
23K |
13M |
24 |
07/01/20 |
07/01/20 |
ASX - By Stock
|
23K
|
13M
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Files GvHD Clinical Efficacy and Safety Data with US FDA
|
|
SarmisGTS
|
73 |
49K |
14 |
02/01/20 |
02/01/20 |
ASX - By Stock
|
73
|
49K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
SarmisGTS
|
17K |
6.5M |
16 |
28/11/19 |
28/11/19 |
ASX - By Stock
|
17K
|
6.5M
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Presentation to 2019 Annual General Meeting
|
|
SarmisGTS
|
36 |
17K |
7 |
28/11/19 |
28/11/19 |
ASX - By Stock
|
36
|
17K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Results of Meeting
|
|
SarmisGTS
|
43 |
20K |
1 |
27/11/19 |
27/11/19 |
ASX - By Stock
|
43
|
20K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Results of Meeting
|
|
SarmisGTS
|
43 |
20K |
5 |
27/11/19 |
27/11/19 |
ASX - By Stock
|
43
|
20K
|
5
|
|